"Sweet Spot" Inside Drug Benefit Turns Sour
This article was originally published in RPM Report
Executive Summary
The "donut hole" inside Part D is proving hard to fill. Some drug insurance plans offered brand coverage in 2006-but they won't be doing that again any time soon. Humana lost a mint offering "complete" coverage, so for now its generics-only in the gap.
You may also be interested in...
The Donut Hole Dilemma: Retaining Lost Patients Under Medicare Part D
Finally, some statistics about the impact of the Medicare Part D donut hole. The good news: drug manufacturers need not worry about most patients entering the coverage gap. The bad: a relatively large number of the industry's best customers do reduce their medication use in the donut hole-and if a customer is lost to the donut hole, they may be lost for good.
The Donut Hole Dilemma: Retaining Lost Patients Under Medicare Part D
Finally, some statistics about the impact of the Medicare Part D donut hole. The good news: drug manufacturers need not worry about most patients entering the coverage gap. The bad: a relatively large number of the industry's best customers do reduce their medication use in the donut hole-and if a customer is lost to the donut hole, they may be lost for good.
Building the Right Foundation: An Interview with Mark McClellan
The Reagan-Udall Foundation is an early priority for FDA in implementing the landmark legislation enacted by Congress in 2007. It is also a lightning road for criticism from Congress about the agency's relationship with regulated industry. We asked foundation chairman Mark McClellan for a status report.